Urologic Outpatient Clinic PURR, Mülheim an der Ruhr, Germany,
Department of Urology, University Hospital Essen, Essen, Germany,
Urol Int. 2020;104(7-8):617-624. doi: 10.1159/000507267. Epub 2020 May 18.
Due to a continuing increase of bacterial resistance in common uropathogens, we wanted to revisit our standards for the diagnosis and treatment of lower urinary tract infections, in the setting of urological outpatient care in a conurbation in Germany.
All subjects presenting with significant bacteriuria at our urology clinics in Mülheim, Germany, in 2011 were included. Comorbidity, bacterial species, urinary tract symptoms, and empirically prescribed antibiotics were taken from the patients' records.
In 2011, a total of 1,324 patients were included (793 female, 531 male). Of the 771 patients with symptomatic bacteriuria, 647 received antibiotic treatment, as well as 116 of 409 patients with asymptomatic bacteriuria. Escherichia coli was identified in 60% of the included patients. In 427 E. coli infections, bacterial resistance was found in 14% of 316 cases treated with quinolone, in 21% of 53 cases treated with co-trimoxazole, and in only 3% of 58 cases treated with nitrofurantoin.
We found a high use of fluoroquinolones for empirical first-line antibiotics in the treatment of lower urinary tract infections. In our regional setting, antibiotic stewardship needs to be promoted, along national and international guidelines, to avoid unnecessary prescription of fluoroquinolones for empirical treatment.
由于常见尿路病原体的细菌耐药性持续增加,我们希望重新审视我们在德国一个城市群的泌尿科门诊护理环境下,诊断和治疗下尿路感染的标准。
纳入 2011 年在德国米尔海姆泌尿科诊所出现明显菌尿的所有患者。从患者记录中获取合并症、细菌种类、尿路症状和经验性开的抗生素。
2011 年,共纳入 1324 例患者(793 例女性,531 例男性)。771 例有症状菌尿患者中,647 例接受了抗生素治疗,409 例无症状菌尿患者中有 116 例接受了治疗。在纳入的患者中,60%为大肠埃希菌。在 427 例大肠埃希菌感染中,用喹诺酮治疗的 316 例中有 14%存在细菌耐药,用复方磺胺甲噁唑治疗的 53 例中有 21%存在细菌耐药,用呋喃妥因治疗的 58 例中仅有 3%存在细菌耐药。
我们发现,在治疗下尿路感染时,氟喹诺酮类药物被大量用作经验性一线抗生素。在我们的地区环境中,需要根据国家和国际指南,促进抗生素管理,以避免不必要地开氟喹诺酮类药物进行经验性治疗。